Abstract

A combination of TORC1 inhibitors increases immune responses to vaccines and decreases overall infection rates in the elderly.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call